Many unresolved questions surrounding the mechanisms of KDM3B and KDM3C in tumorigenesis remain to be disclosed, leaving hope for further pharmacological opportunities to fight cancer using epigenetic therapy. The gene discussed is KDM3B; the disease is cancer.